Healthcare provider profile · identity verified

Duwayne Paul Edge, D.O.

Family Practice · INGLESIDE, TX · NPI 1730152612

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	339	110
Metformin Hcl	Metformin Hcl	331	108
Amlodipine Besylate	Amlodipine Besylate	329	113
Levothyroxine Sodium	Levothyroxine Sodium	265	74
Lisinopril	Lisinopril	264	80
Losartan Potassium	Losartan Potassium	233	81
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	231	34
Metoprolol Succinate	Metoprolol Succinate	215	64
Gabapentin	Gabapentin	172	52
Methylprednisolone	Methylprednisolone	158	113
Tamsulosin Hcl	Tamsulosin Hcl	155	52
Glipizide Er	Glipizide	147	47
Azithromycin	Azithromycin	141	100
Montelukast Sodium	Montelukast Sodium	136	51
Furosemide	Furosemide	120	55
Hydrochlorothiazide	Hydrochlorothiazide	116	40
Albuterol Sulfate Hfa	Albuterol Sulfate	113	60
Mounjaro	Tirzepatide	112	24
Rosuvastatin Calcium	Rosuvastatin Calcium	104	39
Pantoprazole Sodium	Pantoprazole Sodium	98	34
Omeprazole	Omeprazole	97	37
Potassium Chloride	Potassium Chloride	93	37
Fluticasone Propionate	Fluticasone Propionate	86	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	26
Alprazolam	Alprazolam	79	19
Doxycycline Hyclate	Doxycycline Hyclate	79	60
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	32
Eliquis	Apixaban	75	18
Buspirone Hcl	Buspirone Hcl	74	18
Pioglitazone Hcl	Pioglitazone Hcl	72	23
Clopidogrel	Clopidogrel Bisulfate	70	27
Pravastatin Sodium	Pravastatin Sodium	70	28
Allopurinol	Allopurinol	69	23
Trazodone Hcl	Trazodone Hcl	68	18
Meloxicam	Meloxicam	67	32
Tramadol Hcl	Tramadol Hcl	63	19
Famotidine	Famotidine	59	19
Metoprolol Tartrate	Metoprolol Tartrate	59	20
Simvastatin	Simvastatin	54	17
Clonazepam	Clonazepam	52	suppressed
Jardiance	Empagliflozin	52	15
Escitalopram Oxalate	Escitalopram Oxalate	51	20
Alendronate Sodium	Alendronate Sodium	49	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	39
Januvia	Sitagliptin Phosphate	45	13
Ozempic	Semaglutide	45	11
Bupropion Xl	Bupropion Hcl	44	14
Finasteride	Finasteride	44	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	15
Memantine Hcl	Memantine Hcl	43	15
Temazepam	Temazepam	42	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	40	16
Mupirocin	Mupirocin	40	32
Vitamin D2	Ergocalciferol (Vitamin D2)	40	14
Ezetimibe	Ezetimibe	39	14
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	12
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Fenofibrate	Fenofibrate	37	13
Symbicort	Budesonide/Formoterol Fumarate	36	14
Carvedilol	Carvedilol	35	14
Lorazepam	Lorazepam	35	suppressed
Donepezil Hcl	Donepezil Hcl	32	13
Prednisone	Prednisone	31	24
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	25
Sertraline Hcl	Sertraline Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Valsartan	Valsartan	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	12
Nifedipine Er	Nifedipine	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Atenolol	Atenolol	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Lactulose	Lactulose	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Fluconazole	Fluconazole	16	11
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Linzess	Linaclotide	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Trulicity	Dulaglutide	16	suppressed
Baclofen	Baclofen	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	14	14
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Oxycodone Hcl	Oxycodone Hcl	14	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Digoxin	Digoxin	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error